Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
45.06
+0.07 (0.16%)
At close: Oct 30, 2026, 4:00 PM EDT
45.64
+0.58 (1.29%)
After-hours: Oct 30, 2026, 7:58 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $4.03 billion as of October 30, 2026. It is the 4,162nd most valuable company in the world and the 1,310th biggest in the United States. Its market cap has increased by 108.68% in one year.
Market Cap
4.03B
Enterprise Value
3.93B
1-Year Change
108.68%
Global Rank
Country Rank
#1,310 United States
Category
ChartMarket Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.80M to $4.03B, an increase of 2,303.62%. That is a compound annual growth rate of 46.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 4.03B | 34.42% |
| Dec 31, 2025 | 3.00B | 201.47% |
| Dec 31, 2024 | 995.30M | 27.47% |
| Dec 29, 2023 | 780.80M | 90.07% |
| Dec 30, 2022 | 410.80M | 62.31% |
| Dec 31, 2021 | 253.10M | 127.20% |
| Dec 31, 2020 | 111.40M | 39.60% |
| Dec 31, 2019 | 79.80M | -76.20% |
| Dec 31, 2018 | 335.30M | 99.82% |
| Jul 26, 2018 | 167.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiniksa Pharmaceuticals International, | 7.25B |
| Lantheus Holdings | 6.56B |
| Hims & Hers Health | 6.46B |
| Indivior Pharmaceuticals | 4.17B |
| Amylyx Pharmaceuticals | 3.62B |
| Regencell Bioscience Holdings | 3.33B |
| Bausch Health Companies | 3.07B |
| Supernus Pharmaceuticals | 2.44B |